
Clinical and Translational Discovery, Journal Year: 2024, Volume and Issue: 4(5)
Published: Oct. 1, 2024
Clinical and Translational Discovery, Journal Year: 2024, Volume and Issue: 4(5)
Published: Oct. 1, 2024
EMBO Molecular Medicine, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 28, 2025
Abstract As a common and severe cerebrovascular disease, ischemic stroke casts significant shadow over global health. Unfortunately, the mechanisms regulating neuronal death in affected areas remain largely unclear. Here, we found that deletion of deubiquitinating enzyme Otubain-2 (OTUB2) significantly alleviated ischemia-induced cerebral infarction neurological deficits, accompanied by reduction loss, glial activation, neuroinflammation. OTUB2 was predominantly expressed neurons its decreased receptor-interacting protein kinase 3 (RIPK3)-mediated necroptosis. Moreover, increased RIPK3 abundance inhibiting proteasomal degradation RIPK3. Mechanistically, removed K48-linked polyubiquitin chains from through active site C51. Importantly, pharmacological inhibition brain injury mice reduced oxygen-glucose deprivation-induced human organoids. These results demonstrate critically regulates potentiating necroptosis, suggesting may become potential therapeutic approach for treating stroke.
Language: Английский
Citations
1Clinical and Translational Medicine, Journal Year: 2024, Volume and Issue: 14(10)
Published: Oct. 1, 2024
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, but molecular mechanisms underlying IBD are incompletely understood. In this study, we explored role and regulating mechanism otubain 2 (OTUB2), deubiquitinating enzyme, in IBD.
Language: Английский
Citations
4Cell Death and Differentiation, Journal Year: 2025, Volume and Issue: unknown
Published: April 16, 2025
Language: Английский
Citations
0Clinical and Translational Discovery, Journal Year: 2024, Volume and Issue: 4(5)
Published: Oct. 1, 2024
Citations
0